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Ring-Closing Metathesis of Olefinic Peptides:
Design, Synthesis, and Structural Characterization of
Macrocyclic Helical Peptides
Helen E. Blackwell,†,§ Jack D. Sadowsky,‡ Rebecca J. Howard,‡ Joshua N. Sampson,‡ Jeffery A.
Chao,‡ Wayne E. Steinmetz,‡ Daniel J. O'Leary,*,‡,∞ and Robert H. Grubbs*,†
The Arnold and Mabel Beckman Laboratory of Chemical Synthesis, Division of Chemistry and
Chemical Engineering, California Institute of Technology, Pasadena, California 91125, and
Department of Chemistry, Pomona College, Claremont, California 91711
General X-ray Crystallographic Data for Cyclic Peptide 8.  Clear, colorless crystals of
cyclic peptide 8 were obtained by slow diffusion from CH2Cl2/hexane at room temperature (20-
25°C).  The dimensions of the crystal analyzed were: 0.3 x 0.5 x 0.5 mm.  The crystals belong to
the orthorhombic system with unit cell parameters at 156 K: a = 19.30(1) Å, b = 24.73(2) Å, c =
12.134(7) Å, and V = 5791(6) Å3.  The space group is P212121 with Z = 4 formula units/unit cell
and ρ (calcd) = 1.246 g/cm3.  Intensity data (4698 total) was collected on a Picker (Crystal
Logic) diffractometer system using monchromatized MoKα radiation (λ = 0.7107 Å) via an θ-2θ
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scan technique.  Those 2266 reflections with |Io| > 3σ(|Io|) were considered observed.  An
absorption correction was not applied.
The structure was solved by Direct Methods using the UCLA Crystallographic
Computing Package1 and SHELXTL 86 program set,2 and refined by full-matrix least-squares
techniques.  There are two molecules of CH2Cl2 and one molecule of H2O present per one
peptide molecule.  Hydrogen atoms were included using a riding model with d(C-H) = 0.96 Å
and U(iso) = 0.08 Å2.  At convergence, RF = 6.6%, RwF = 7.7% and GOF = 2.28 for 633
variables.
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Crystallographic data (excluding structure factors) for structure 8 have been deposited
with the Cambridge Crystallographic Data Centre as supplementary publication no. CCDC-
101810.  Copies of the data can be obtained free of charge on application to CCDC, 12 Union
Road, Cambridge CB2 1EZ, UK (fax: (+44)1223-336-033; e-mail: deposit@ccdc.cam.ac.uk).
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Table S1.  Details of X-ray data collection and structure refinement for cyclic
peptide 8.
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Table S2.  Distances, angles and torsion angles for the solid-state structure of cyclic peptide 8.   
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Table S2.  Distances, angles and torsion angles for the solid-state structure of cyclic peptide 8 (cont.)
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Table S2.  Distances, angles and torsion angles for the solid-state structure of cyclic peptide 8 (cont.)
Table S3.  Position and displacement parameters for the solid-state structure of cyclic peptide 8.
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Table S3.  Position and displacement parameters for the solid-state structure of cyclic peptide 8 (cont.)
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Table S3. Position and displacement parameters
for the solid-state structure of cyclic peptide 8
(cont.)
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Table S3.  Position and displacement parameters
for the solid-state structure of cyclic peptide 8
(cont.)
Figure S1.  stereoview of ORTEP diagram for cyclic peptide 8.
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Figure S2.  Unit cell of cyclic peptide 8.
Figure S3.  Stereoview of unit cell of cyclic peptide 8.
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Figure S4.  Six molecules from the unit cell of cyclic peptide 8.
Figure S5.  Unit cell of cyclic peptide 8 including solvent molecules.
S12
Table S4.  1H NMR data for acyclic peptide 4 (30 mM, CD2Cl2,
25 °C).  All atoms are labeled moving out from the α carbon in
the order:  α, β, γ, δ , ε, ζ , and η .  In cases of magnetic
inequivalence of diastereotopic protons, the higher field proton
was arbitrarily labeled with a prime (,) symbol because
stereospecific assignments were not made.
Residue Proton δ (ppm)
BOC CH3 1.48
Val1 NH (JNHα = 2.0 Hz) 5.03
αH (Jαβ = 4.4 Hz) 3.75
βH 2.12
γH 1.02
γ’H 0.99
Hse2 NH (JNHα = 3.4 Hz) 8.11
αH (Jαβ1 = 4.4 Hz, Jαβ2 = 8.3 Hz) 4.19
βH 2.14
β’H 1.96
γH 3.65
γ’H 3.50
εH 3.99
ζH 5.95
ηcisH 5.25
ηtransH 5.32
Leu3 NH (JNHα = 6.4 Hz) 7.37
αH (overlap with Val5αH) 4.47
βH, β’H ~1.7
γH ~1.7
δH 0.95
δ’H 0.88
Aib4 NH 7.61
βCH3 1.50
β’CH3 1.46
Val5 NH (JNHα = 6.4 Hz) 6.89
αH (Jαβ = 4.4 Hz) 4.08
βH 2.40
γH, γ’H 1.01
Hse6 NH (JNHα = 8.1 Hz) 7.55
αH (Jαβ1 = 3.9 Hz, Jαβ2 = 11.3 Hz) 4.37
βH 2.22
β’H 1.96
γH 3.52
γ’H 3.50
εH 3.91
ζH 5.87
ηcisH 5.09
ηtransH 5.21
Leu7 NH (JNHα = 8.1 Hz) 7.21
αH (Jαβ1 = 5.5 Hz, Jαβ2 = 8.6 Hz) 4.47
βH, β’H ~1.7
γH ~1.7
δH, δ’H 0.89
OMe CH3 3.68
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Table S5.  1H NMR data for cyclic peptide 8 (30 mM, CD2Cl2, 25
°C).  All atoms are labeled moving out from the α carbon in the
order:  α, β, γ, δ, ε, ζ, and η.  In cases of magnetic inequivalence
of diastereotopic protons, the higher field proton was arbitrarily
labeled with a prime (,) symbol because stereospecific
assignments were not made.
Residue Proton δ (ppm)
BOC CH3 1.49
Val1 NH (JNHα = 2.0 Hz) 5.17
αH (Jαβ = 4.4 Hz) 3.82
βH 2.16
γH 1.04
γ’H 0.99
Hse2 NH (JNHα = 3.9 Hz) 6.76
αH (overlap with Val5αH) 4.18
βH 2.34
β’H 1.77
γH, γ’H 3.50
εH 3.26
ζH 1.35
Leu3 NH (JNHα = 3.9 Hz) 7.24
αH (Jαβ1 = 4.6 Hz, Jαβ2 = 7.8 Hz) 3.98
βH, β’H 1.61
γH 1.78
δH 0.97
δ’H 0.92
Aib4 NH 7.48
βCH3 1.68
β’CH3 1.47
Val5 NH (JNHα = 7.8 Hz) 7.83
αH (Jαβ = 6.9 Hz) 4.18
βH 2.45
γH 1.07
γ’H 1.00
Hse6 NH (JNHα = 8.8 Hz) 7.55
αH (Jαβ1 = 3.4 Hz, Jαβ2 = 11.5 Hz) 4.27
βH, β’H 2.12
γH 3.51
γ’H 3.38
εH 3.38
ζH 1.52
Leu7 NH (JNHα = 8.3 Hz) 7.05
αH (Jαβ1 = 6.4 Hz, Jαβ2 = 8.5 Hz) 4.48
βH, β’H 1.64
γH 1.74
δH 0.89
δ’H 0.87
OMe CH3 3.69
S14
Table S6.  Interproton distance restraints for peptides 4 and 8 calculated by integration of the crosspeaks
in Tr-ROESY spectra (CD2Cl2 (c = 30 mM), 25 °C, 2048 x 256 data matrix, 16 scans/FID, 600 msec
composite spin-lock pulse).3  Restraints added in the second refinement round of calculation are shaded
in gray.
Acyclic Peptide 4 (32 restraints) Cyclic Peptide 8 (35 restraints)
Proton Pair Restraint Upper-Bound
(Å)
Proton Pair Restraint Upper-Bound
(Å)
Val1NH, Val1α 3 Val1NH, Val1α 3
Hse2NH, Hse2α 3 Leu3NH, Leu3α 3
Hse6NH, Hse6α 3 Hse6NH, Hse6α 3
Leu7NH, Leu7α 3 Leu7NH, Leu7α 3
Val5NH, Val5β 3 Val5NH, Val5β 3
Hse6α, Leu7NH 3 Val1α, Hse2NH 4
Val1NH, Hse2NH 3 Leu3α, Aib4NH 4
Hse2NH, Leu3NH 3 Hse6α, Leu7NH 3
Leu3NH, Aib4NH 3 Val1NH, Hse2NH 4
Aib4NH, Val5NH 3 Hse2NH, Leu3NH 4
Val5NH, Hse6NH 3 Leu3NH, Aib4NH 3
Hse6NH, Leu7NH 3 Aib4NH, Val5NH 3
Leu3NH, Leu3α 3 Val5NH, Hse6NH 3
Val5NH, Val5α 3 Hse6NH, Leu7NH 3
Hse2NH, Hse2ε 5 Val1α, Leu3NH 4
Val1α, Hse2NH 4 Leu3α, Hse6NH 4
Hse2α, Leu3NH 4 Val1α, Aib4NH 4
Leu3α, Aib4NH 4 Leu3α, Val5NH 4
Hse2β/β’, Leu3NH 5 Hse2NH, Hse2α 3
Aib4β/β’, Val5NH 5 Hse2α, Leu3NH 4
Val5β, Hse6NH 4 Val5α, Hse6NH 4
Hse6β/β’, Leu7NH 5 Val5α, Aib4β/β’ 5
Val1γ/γ’, Hse2NH 5 Val1β, Hse2NH 4
Val5γ/γ’, Hse6NH 7 Aib4β/β’, Val5NH 5
Val1α, Leu3NH 4 Hse6β/β’, Leu7NH 5
Hse2α, Aib4NH 4 Val1γ/γ’, Hse2NH 7
Val5α, Leu7NH 4 Hse2γ/γ’, Leu3NH 6
Aib4β/β’, Hse6NH 6 Hse2α, Aib4NH 4
Val1α, Aib4NH 4 Leu3α, Hse6β/β’ 5
Val1NH, BOC 8 Leu3α, Hse6ε 6
Hse2NH, BOC 8 Val1NH, BOC 8
Hse2ζ, BOC 8 Val1α, BOC 8
Leu7α, OMe 5
Hse2NH, BOC 8
Leu3NH, BOC 8
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Figure S6.  Phi-Psi maps for all seven residues in refined conformations of acyclic
peptide 4.  Data for ideal 310- and α-helices are also shown.
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Figure S7.  Phi-Psi maps for all seven residues in refined conformations of cyclic peptide
8.  Data for ideal 310- and α-helices are also shown.  CH = cyclic peptide helix 8.
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Figure S8.  Rendered images of SYBYL .mol2 files for five calculated families (I-V) of conformers for acyclic
peptide 4.4    
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Figure S8.  Rendered image of  SYBYL .mol2 files for five calculated families (I-V) of conformers for acyclic
peptide 4 (cont.)4
Figure S9.  Two rendered images of SYBYL .mol2 files (a, b) for one calculated family of conformers for cyclic
peptide 8.4
V
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